| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.053 | 0.3 |